Why INJ faltered above $17.50 despite Injective’s breakthroughs

2 years ago 46

The launch of the BUIDL index highlights Injective's capabilities in the decentralized finance and asset tokenization niches.

1. Homepage
2. cryptocurrency
3. Why INJ faltered above $17.50 despite Injective’s breakthroughs